Latest stories on ALLR
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity updates on recent advances in Drug Response Predictor technology
The Fly63 · neutralproduct/pr
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Business Insider63 · neutralproduct/pr
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity expands lab capabilities to include proteomics, cell line research
The Fly63 · neutralproduct/pr
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
GlobeNewswire63 · neutralproduct/pr
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Business Insider63 · neutralproduct/pr
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
Business Insider63 · neutralproduct/pr
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
GlobeNewswire63 · neutralproduct/pr
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
GlobeNewswire56 · neutralgeneral
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
Business Insider56 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics reports Q2 results
Seeking Alpha53 · neutralearnings
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Business Insider59 · neutralproduct/pr
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
GlobeNewswire56 · neutralearnings
Allarity Wins Key U.S. Patent for Stenoparib Diagnostic
TipRanks63 · neutralproduct/pr
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics Updates CEO Management and Compensation Agreement
TipRanks50 · neutralgeneral